15-Nov-24 |
Buy |
Heikki Lanckriet |
1,325.00p | 46,500 |
£616,125.00 |
15-Nov-24 |
Sell |
Heikki Lanckriet |
1,325.00p | 46,500 |
£616,125.00 |
15-Nov-24 |
Sell |
Heikki Lanckriet |
1,325.00p | 46,500 |
£616,125.00 |
15-Nov-24 |
Buy |
Heikki Lanckriet |
1,325.00p | 46,500 |
£616,125.00 |
Heikki Lanckriet |
1,103,288 |
£14,526,625 |
Maria Del Pilar de la Huerta |
6,667 |
£87,782 |
Hansjörg Plaggemars |
6,667 |
£87,782 |
Timothy Paul McCarthy |
2,388 |
£31,442 |
Wilhelm K. T. Zours |
5,071,073 |
£66,769,128 |
DELPHI Unternehmensberatung AG |
5,071,073 |
£66,769,128 |
M&G Plc |
4,627,741 |
£60,931,923 |
Elevage Medical Technologies Holdings |
4,627,741 |
£60,931,923 |
Deutsche Balaton AG |
4,432,637 |
£58,363,054 |
4bb AG |
3,665,242 |
£48,259,020 |
2invest AG |
2,229,083 |
£29,349,593 |
Sparta AG |
1,351,718 |
£17,797,620 |
Latonba AG |
757,259 |
£9,970,577 |
Franciscus De Busschere |
537,255 |
£7,073,858 |
CEO |
Heikki Lanckriet |
CFO |
David John Roth |
Top of Page
You are here:
research